The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Apixaban Rowex 2.5 mg film-coated tablets

Rowex LtdPA0711/303/001

Main Information

Trade NameApixaban Rowex 2.5 mg film-coated tablets
Active SubstancesApixaban
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/303/001

Group Information

ATC CodeB01AF02 apixaban


License statusAuthorised
Licence Issued17/09/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

Generics Information

Interchangeable List CodeIC0124-018-003
Interchangeable List DocumentPDF of Interchangeable List
« Back